Abcodia

About:

Abcodia is a biotechnology company that focuses on the discovery and validation of biomarkers for cancer screening.

Twitter/X: abcodia

Top Investors: Cambridge Innovation Capital, AlbionVC, EASME - EU Executive Agency for SMEs, Scottish Equity Partners, UCLB

Description:

Abcodia is a biotechnology company that focused on the discovery and validation of biomarkers for cancer screening. With its unique longitudinal serum biobank and partnerships with UCL, technology platform providers, and leading commercial diagnostic companies, Abcodia is able to support the end-to-end diagnostic development process. Abcodia was founded in 2010 and is based in Cambridge, UK.

Total Funding Amount:

$10.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Cambridgeshire, United Kingdom

Founded Date:

2010-01-01

Contact Email:

info(AT)abcodia.com

Founders:

Julie Barnes, Michael De Grado

Number of Employees:

1-10

Last Funding Date:

2015-05-18

IPO Status:

Private

Industries: